Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant Organisms

NCT05632315 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05632315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05632315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant Organisms
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
August 19, 2024
Completion date
August 24, 2026
Enrollment
32 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

enterobacteriaceae infections, methicillin-resistant staphylococcus aureus, multidrug resistant bacterial infection, pseudomonas aeruginosa, vre infection